Reclassification of Acquired in Process Research and Development from indefinite-lived to definite-lived

No definition available.

Name:	stj_ReclassificationofAcquiredinProcessResearchandDevelopmentfromindefinitelivedtodefinitelived
Namespace Prefix:	stj_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.

+ References

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stj_CardioMEMSIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stj_EndosenseS.A.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Goodwill And Other Intangible Assets Goodwill And Other Intangible Assets Narrative (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Jan. 03, 2015	Dec. 28, 2013	Dec. 29, 2012
Operating Expense [Member]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 58	$ 29
Operating Expense [Member] \| Developed Technology Rights [Member]
Intangible asset impairment charges, Finite-lived			31
Operating Expense [Member] \| Customer Relationships [Member]
Intangible asset impairment charges, Finite-lived		13
Operating Expense [Member] \| In Process Research and Development [Member]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	50	15
Operating Expense [Member] \| Trade Names [Member]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	8	14
CardioMEMS, Inc [Member]
Reclassification of Acquired in Process Research and Development from indefinite-lived to definite-lived	63
CardioMEMS, Inc [Member] \| Developed Technology Rights [Member]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	11 years
Endosense S.A. [Member]
Reclassification of Acquired in Process Research and Development from indefinite-lived to definite-lived	$ 33
Endosense S.A. [Member] \| Developed Technology Rights [Member]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	7 years